Research Article | | Peer-Reviewed

Antioxidant and Antiplasmodial Potentials of Methanol Bark Extract of Entada africana Via in Vitro Approaches

Received: 14 May 2024     Accepted: 4 June 2024     Published: 30 August 2024
Views:       Downloads:
Abstract

Plasmodium parasites, which cause malaria, continue to pose a serious threat to global health, necessitating the continuous search for novel antimalarial agents. Oxidative stress has also been linked to the pathophysiology of malaria. Entada africana is a plant known for its ethnomedicinal uses in treating various ailments associated with inflammation including malaria. This study aimed at evaluating the antiplasmodial and antioxidant potentials of methanol bark extract from Entada africana (MBEEA). In vitro approaches were adopted for the study. Plasmodium falciparum-infected erythrocyte samples were cultured in Roswell Park Memorial Institute (RPMI) 1640 media under anaerobic conditions for 72 hours. Eighteen test tubes were labeled and grouped into three replicates per group. Group I (untreated), Group II, and III were treated with chloroquine (CQ) and artemether (AR) at a concentration of 5 mg/dL. Group IV, V, and VI were treated with the extract at respective concentrations of 5 mg/dL, 10 mg/dL, and 20 mg/dL for 72 hours. The parasitemia count and the percentage parasitemia inhibition were determined by microscopic examination of Giemsa-stained smears. The antioxidant potential of the extract was assessed using in vitro assays, including superoxide radical scavenging activity (SRSA), hydroxyl radical scavenging activity (HRSA), 1,1-diphenyl-2-picrylhydrazyl (DPPH), and ferric reducing antioxidant power (FRAP). Microscopic examination of the treated samples revealed varying degrees of parasitemia inhibition. Group II and III treated with CQ and AR demonstrated a considerable reduction in parasitemia count with percentage inhibition of 100% and 83% respectively. The E. africana extract showed a concentration-dependent effect on parasitemia count. At 5 mg/dL, the extract exhibited 50% parasitemia inhibition, which increased to 100% at 10 mg/dL, and 20 mg/dL respectively. The MBEEA demonstrated significant in vitro antioxidant activities by scavenging DPPH, SRSA, and hydroxyl radical compared to the standard antioxidant (ascorbic acid). MBEEA thus exhibit potent antioxidant and antiplasmodial properties. This plant is therefore offers to be a promising medicinal plant in the treatment of malaria, hence it is recommended as potent antiplasmodial plant usable for treating malaria.

Published in American Journal of Biomedical and Life Sciences (Volume 12, Issue 4)
DOI 10.11648/j.ajbls.20241204.11
Page(s) 57-67
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Plasmodium falciparum-infected Erythrocytes, MBEEA, Antioxidant Potential, Parasitemia Counts, Chloroquine, Artemether

References
[1] Aliyu, A. W., Mustaffa, K. M. F., Yew, L. C. and Hou, L. J. (2021). Chloroquine bioconjugates and hybrid compounds: past and recent developments in combatting chloroquine resistant malaria. Tropical Journal of Pharmaceutical Research, 20(12).
[2] Baldé, M. A., Tuenter, E., Traoré, M. S., Matheeussen, A., Cos, P., Maes, L. and Foubert, K. (2020). Antimicrobial investigation of ethnobotanically selected guinean plant species. Journal of Ethnopharmacology, 263: 113232.
[3] Balunas, M. J. and Kinghorn, A. D. (2005). Drug discovery from medicinal plants. Life Sciences, 78(5): 431-441.
[4] Beshir, K. B., Sutherland, C. J., Sawa, P., Drakeley, C. J., Okell, L., Mweresa, C. K. and Bousema, T. (2013). Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. The Journal of Infectious Diseases, 208(12): 2017-2024.
[5] Das, D., Dahal, P., Dhorda, M., Citarella, B. W., Kennon, K., Stepniewska, K. and Guerin, P. J. (2021). A systematic literature review of microscopy methods reported in malaria clinical trials. The American Journal of Tropical Medicine and Hygiene, 104(3): 836.
[6] Dias, D. A., Urban, S. and Roessner, U. (2012). A historical overview of natural products in drug discovery. Metabolites, 2(2): 303-336.
[7] Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J. and White, N. J. (2009). Artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine, 361(5): 455-467.
[8] Ezenyi, I. C., Ranarivelo, L., Oluwakanyinsola, S. A. and Emeje, M. (2014). Analgesic, anti-inflammatory, and heme biomineralization inhibitory properties of Entada africana ethanol leaf extract with antiplasmodial activity against Plasmodium falciparum. Journal of Basic and Clinical Physiology and Pharmacology, 25(2): 217-223.
[9] Hernandez, E. P., Anisuzzaman, Alim, M. A., Kawada, H., Kwofie, K. D., Ladzekpo, D. and Hatta, T. (2022). Ambivalent Roles of Oxidative Stress in Triangular Relationships among Arthropod Vectors, Pathogens and Hosts. Antioxidants, 11(7): 1254.
[10] Karou, S. D., Tchacondo, T., Ouattara, L., Anani, K., Savadogo, A., Agbonon, A. and Simpore, J. (2011). Antimicrobial, antiplasmodial, haemolytic and antioxidant activities of crude extracts from three selected Togolese medicinal plants. Asian Pacific Journal of Tropical Medicine, 4(10): 808-813.
[11] Kavishe, R. A., Koenderink, J. B. and Alifrangis, M. (2017). Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons. The FEBS journal, 284(16): 2579-2591.
[12] Marquardt P., Codo-Toafode M., Henning L., Ayhi V., Fester K. (2017). Identification and Characterization of Active Compounds from Medicinal Plants Traditionally Used in Benin.
[13] Matz, J. M. (2022). Plasmodium ’s bottomless pit: properties and functions of the malaria parasite's digestive vacuole. Trends in Parasitology. 38(7): 525-543.
[14] Mokrani, A. and Madani, K. (2016). Effect of solvent, time and temperature on the extraction of phenolic compounds and antioxidant capacity of peach (Prunus persica L.) fruit. Separation and Purification Technology, 162: 68-76.
[15] Okawa, M., Kinjo, J., Nohara, T. and ONO, M. (2001). DPPH (1, 1-diphenyl-2-picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants. Biological and Pharmaceutical Bulletin, 24(10): 1202-1205.
[16] Openshaw, R., Maepa, K., Benjamin, S. J., Wainwright, L., Combrinck, J. M., Hunter, R. and Egan, T. J. (2021). A diverse range of hemozoin inhibiting scaffolds act on Plasmodium falciparum as heme complexes. ACS infectious diseases, 7(2): 362-376.
[17] Orth, H., Jensen, B. O., Holtfreter, M. C., Kocheril, S. J., Mallach, S., MacKenzie, C.,... and Richter, J. (2013). Plasmodium knowlesi infection imported to Germany, January 2013. Eurosurveillance, 18(40): 20603.
[18] Overstreet, M. G., Cockburn, I. A., Chen, Y. C. and Zavala, F. (2008). Protective CD8+ T cells against Plasmodium liver stages: immunobiology of an ‘unnatural’immune response. Immunological reviews, 225(1): 272-283.
[19] Padilla-Rodríguez, J. C., Olivera, M. J. and Guevara-García, B. D. (2020). Parasite density in severe malaria in Colombia. PLoS One, 15(6): e0235119.
[20] Rani, A., Sharma, A., Legac, J., Rosenthal, P. J., Singh, P. and Kumar, V. (2021). A trio of quinoline-isoniazid-phthalimide with promising antiplasmodial potential: Synthesis, in-vitro evaluation and heme-polymerization inhibition studies. Bioorganic and Medicinal Chemistry, 39: 116159.
[21] Rasoanaivo P., Wright C. W., Willcox M. L. and Gilbert B. (2011). Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malaria Journal. 10(Suppl 1): S4.
[22] Rates, S. M. K. (2001). Plants as source of drugs. Toxicon, 39(5): 603-613.
[23] Tam, D. N. H., Tawfik, G. M., El-Qushayri, A. E., Mehyar, G. M., Istanbuly, S., Karimzadeh, S. and Huy, N. T. (2020). Correlation between anti-malarial and anti-hemozoin activities of anti-malarial compounds. Malaria Journal, 19(1): 1-12.
[24] Tang, Y. Q., Ye, Q., Huang, H. and Zheng, W. Y. (2020). An overview of available antimalarials: discovery, mode of action and drug resistance. Current Molecular Medicine, 20(8): 583-592.
[25] Teixeira, C., Vale, N., Perez, B., Gomes, A., Gomes, J. R. and Gomes, P. (2014). “Recycling” classical drugs for malaria. Chemical reviews, 114(22): 11164-11220.
[26] Tibiri, A., Sawadogo, R. W., Ouedraogo, B. J. T., Guissou, I. P. and Nacoulma, G. O. (2010). Evaluation of antioxidant activity, total phenolic and flavonoid content of Entada africana Guill. Et Perr. (Mimosaceae) organ extracts. Research Journal of Medical Sciences, 4(2): 81–87.
[27] Trager, W. and Jensen, J. B. (1980). Cultivation of erythrocytic and exoerythrocytic stages of plasmodia. In Pathology, Vector Studies, and Culture (pp. 271-319). Academic Press.
[28] Um, J. H., Kim, E. A., Lee, W., Kang, N., Han, E. J., Oh, J. Y. and Ahn, G. (2017). Protective effects of an enzymatic hydrolysate from Octopus ocellatus meat against hydrogen peroxide-induced oxidative stress in Chang liver cells and zebrafish embryo. In Taurine 10 (pp. 603-620). Springer Netherlands.
[29] Vasquez, M., Zuniga, M. and Rodriguez, A. (2021). Oxidative stress and pathogenesis in malaria. Frontiers in cellular and infection microbiology, 11: 768182.
[30] World Health Organization Traditional Medicines. (2008). Guidelines for the treatment of malaria. World Health Organization.
[31] World Health Organization. (2013). Guidelines for the treatment of malaria. World Health Organization.
[32] World Health Organization. (2015). Guidelines for the treatment of malaria. World Health Organization.
[33] Wu, D. and Cederbaum, A. I. (2003). Alcohol, oxidative stress, and free radical damage. Alcohol research and health, 27(4): 277.
[34] Yu, J., Li, W., You, B., Yang, S., Xian, W., Deng, Y. and Yang, R. (2021). Phenolic profiles, bioaccessibility and antioxidant activity of plum (Prunus Salicina Lindl). Food Research International, 143: 110300.
[35] Yusuf, A. J. and Abdullahi, M. I. (2019). The phytochemical and pharmacological actions of Entada africana Guill. and Perr. Heliyon, 5(9): e02332.
[36] Zakiah, M., Syarif, R. A., Mustofa, M., Jumina, J., Fatmasari, N. and Sholikhah, E. N. (2021). In vitro antiplasmodial, heme polymerization, and cytotoxicity of hydroxyxanthone derivatives. Journal of Tropical Medicine, 2021.
Cite This Article
  • APA Style

    Olusola, A. O., Okoh, E. F., Ekun, O. E., Elekan, A. O., Fakoya, A., et al. (2024). Antioxidant and Antiplasmodial Potentials of Methanol Bark Extract of Entada africana Via in Vitro Approaches. American Journal of Biomedical and Life Sciences, 12(4), 57-67. https://doi.org/10.11648/j.ajbls.20241204.11

    Copy | Download

    ACS Style

    Olusola, A. O.; Okoh, E. F.; Ekun, O. E.; Elekan, A. O.; Fakoya, A., et al. Antioxidant and Antiplasmodial Potentials of Methanol Bark Extract of Entada africana Via in Vitro Approaches. Am. J. Biomed. Life Sci. 2024, 12(4), 57-67. doi: 10.11648/j.ajbls.20241204.11

    Copy | Download

    AMA Style

    Olusola AO, Okoh EF, Ekun OE, Elekan AO, Fakoya A, et al. Antioxidant and Antiplasmodial Potentials of Methanol Bark Extract of Entada africana Via in Vitro Approaches. Am J Biomed Life Sci. 2024;12(4):57-67. doi: 10.11648/j.ajbls.20241204.11

    Copy | Download

  • @article{10.11648/j.ajbls.20241204.11,
      author = {Adesayo Olufunmi Olusola and Ehisdiame Favour Okoh and Oluwafemi Emmanuel Ekun and Ayodele Oluwasegun Elekan and Akindele Fakoya and Augustine Olusegun Olusola},
      title = {Antioxidant and Antiplasmodial Potentials of Methanol Bark Extract of Entada africana Via in Vitro Approaches
    },
      journal = {American Journal of Biomedical and Life Sciences},
      volume = {12},
      number = {4},
      pages = {57-67},
      doi = {10.11648/j.ajbls.20241204.11},
      url = {https://doi.org/10.11648/j.ajbls.20241204.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20241204.11},
      abstract = {Plasmodium parasites, which cause malaria, continue to pose a serious threat to global health, necessitating the continuous search for novel antimalarial agents. Oxidative stress has also been linked to the pathophysiology of malaria. Entada africana is a plant known for its ethnomedicinal uses in treating various ailments associated with inflammation including malaria. This study aimed at evaluating the antiplasmodial and antioxidant potentials of methanol bark extract from Entada africana (MBEEA). In vitro approaches were adopted for the study. Plasmodium falciparum-infected erythrocyte samples were cultured in Roswell Park Memorial Institute (RPMI) 1640 media under anaerobic conditions for 72 hours. Eighteen test tubes were labeled and grouped into three replicates per group. Group I (untreated), Group II, and III were treated with chloroquine (CQ) and artemether (AR) at a concentration of 5 mg/dL. Group IV, V, and VI were treated with the extract at respective concentrations of 5 mg/dL, 10 mg/dL, and 20 mg/dL for 72 hours. The parasitemia count and the percentage parasitemia inhibition were determined by microscopic examination of Giemsa-stained smears. The antioxidant potential of the extract was assessed using in vitro assays, including superoxide radical scavenging activity (SRSA), hydroxyl radical scavenging activity (HRSA), 1,1-diphenyl-2-picrylhydrazyl (DPPH), and ferric reducing antioxidant power (FRAP). Microscopic examination of the treated samples revealed varying degrees of parasitemia inhibition. Group II and III treated with CQ and AR demonstrated a considerable reduction in parasitemia count with percentage inhibition of 100% and 83% respectively. The E. africana extract showed a concentration-dependent effect on parasitemia count. At 5 mg/dL, the extract exhibited 50% parasitemia inhibition, which increased to 100% at 10 mg/dL, and 20 mg/dL respectively. The MBEEA demonstrated significant in vitro antioxidant activities by scavenging DPPH, SRSA, and hydroxyl radical compared to the standard antioxidant (ascorbic acid). MBEEA thus exhibit potent antioxidant and antiplasmodial properties. This plant is therefore offers to be a promising medicinal plant in the treatment of malaria, hence it is recommended as potent antiplasmodial plant usable for treating malaria.
    },
     year = {2024}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Antioxidant and Antiplasmodial Potentials of Methanol Bark Extract of Entada africana Via in Vitro Approaches
    
    AU  - Adesayo Olufunmi Olusola
    AU  - Ehisdiame Favour Okoh
    AU  - Oluwafemi Emmanuel Ekun
    AU  - Ayodele Oluwasegun Elekan
    AU  - Akindele Fakoya
    AU  - Augustine Olusegun Olusola
    Y1  - 2024/08/30
    PY  - 2024
    N1  - https://doi.org/10.11648/j.ajbls.20241204.11
    DO  - 10.11648/j.ajbls.20241204.11
    T2  - American Journal of Biomedical and Life Sciences
    JF  - American Journal of Biomedical and Life Sciences
    JO  - American Journal of Biomedical and Life Sciences
    SP  - 57
    EP  - 67
    PB  - Science Publishing Group
    SN  - 2330-880X
    UR  - https://doi.org/10.11648/j.ajbls.20241204.11
    AB  - Plasmodium parasites, which cause malaria, continue to pose a serious threat to global health, necessitating the continuous search for novel antimalarial agents. Oxidative stress has also been linked to the pathophysiology of malaria. Entada africana is a plant known for its ethnomedicinal uses in treating various ailments associated with inflammation including malaria. This study aimed at evaluating the antiplasmodial and antioxidant potentials of methanol bark extract from Entada africana (MBEEA). In vitro approaches were adopted for the study. Plasmodium falciparum-infected erythrocyte samples were cultured in Roswell Park Memorial Institute (RPMI) 1640 media under anaerobic conditions for 72 hours. Eighteen test tubes were labeled and grouped into three replicates per group. Group I (untreated), Group II, and III were treated with chloroquine (CQ) and artemether (AR) at a concentration of 5 mg/dL. Group IV, V, and VI were treated with the extract at respective concentrations of 5 mg/dL, 10 mg/dL, and 20 mg/dL for 72 hours. The parasitemia count and the percentage parasitemia inhibition were determined by microscopic examination of Giemsa-stained smears. The antioxidant potential of the extract was assessed using in vitro assays, including superoxide radical scavenging activity (SRSA), hydroxyl radical scavenging activity (HRSA), 1,1-diphenyl-2-picrylhydrazyl (DPPH), and ferric reducing antioxidant power (FRAP). Microscopic examination of the treated samples revealed varying degrees of parasitemia inhibition. Group II and III treated with CQ and AR demonstrated a considerable reduction in parasitemia count with percentage inhibition of 100% and 83% respectively. The E. africana extract showed a concentration-dependent effect on parasitemia count. At 5 mg/dL, the extract exhibited 50% parasitemia inhibition, which increased to 100% at 10 mg/dL, and 20 mg/dL respectively. The MBEEA demonstrated significant in vitro antioxidant activities by scavenging DPPH, SRSA, and hydroxyl radical compared to the standard antioxidant (ascorbic acid). MBEEA thus exhibit potent antioxidant and antiplasmodial properties. This plant is therefore offers to be a promising medicinal plant in the treatment of malaria, hence it is recommended as potent antiplasmodial plant usable for treating malaria.
    
    VL  - 12
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Sections